Company page
Celltrion Pharm Inc.
Celltrion Pharm Inc. is a public company listed under the ticker 068760 on the Korean market. The company has a market capitalization of approximately 1.21 billion USD. Celltrion Pharm focuses on the development and commercialization of biopharmaceutical products.
- Ticker
- 068760:KRX
- Asset type
- Stock
- Market cap
- $1.21B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW